SRNT 9th Annual Meeting

February 19-22, 2003

Program Highlights

The SRNT 's 9th Annual Meeting will center around a variety of themes, including international issues and topics of basic, clinical and public health sciences, and will include invited addresses by leaders in these fields. This year's program also will include state of the science symposia, oral presentations, roundtable discussions, and a new investigator paper session. A vital component of the program will be poster sessions that present the most recent research findings in the field of nicotine and tobacco and will take place throughout the conference. In addition, SRNT will have pre-and post-conference meetings.

Keynote Speaker

Dr. C. Everett Koop, former Surgeon General of the United States and currently Senior Scholar and Elizabeth DeCamp McInerny Professor of Surgery at the C. Everett Koop Institute, Dartmouth College. On Thursday, February 20, at 9:00 a.m. Dr. Koop will describe his vision of global tobacco research and control for the next decade.

Listed below is the preliminary program. A complete schedule will be available in December. For more information, please contact the SRNT National Office at 608-443-2462, ext. 130.

SRNT 9^th Annual Meeting

Preliminary Program*

*Please note: dates and times for poster, paper and symposia sessions may change without notice.

Wednesday, February 19, 2003
8:30 a.m. - 5:30 p.m.	Pre-Conference Meeting Global Initiatives in Tobacco Research
For more information on the Global Initiatives Meeting, please view the GI flyer (pdf document).
Registration for the Global Initiative Symposium is free. However, space is limited and early registration is recommended.
10:00 a.m. - 5:30 p.m.	Pre-Conference Symposium: Smoking Cessation Pharmacotherapy: Accelerating Discovery-to-Delivery
Tobacco addiction constitutes not only a hugely prevalent drug abuse problem in its own right; tobacco use and nicotine dependence also accompany the abuse of other substances such as alcohol, and the consequences of tobacco use beyond addiction are frankly devastating for human health. For these reasons, NIDA, NCI and NIAAA are jointly committed to make contributions to the discovery, development and delivery of effective treatments for tobacco addiction, and we have initiated collaborative efforts to achieve progress. This symposium will consist of three components which will feature examples from our mutual efforts in the discovery of targets for potential medications, the development of medications based on a platform of existing targets, and the delivery and adoption of medications. In addition, the symposium will describe our overarching plans for our future efforts. During the Discovery section of the program, speakers will address the most recent findings in the fields of nicotinic receptor biology and CNS neurochemical systems such as GABA and glutamate that play a role in the effects of nicotine. In addition, discussion will inform the question of the nature of model systems that might be used to advance the discovery agenda. The Development section of the program will provide a background to the drug development process itself, and in addition feature presentations on emerging medications, such as antidepressants and nicotine vaccines, as well as an overview of medications in late-phase development. In the final section of the program, Delivery, the focus will shift to strategies to improve the delivery of medications, as well as challenges to delivery and models in the health care system and beyond for the effective delivery and use of medications.
There is no fee for this symposium, but space is limited. Pre-registration is mandatory.
5:30 p.m. - 8:00 p.m.	Reception Open to all SRNT conference and pre-conference attendees
7:30 p.m. - 9:30 p.m.	Interactive Workshop on Future Directions for Global Tobacco Research
Thursday, February 20, 2003
8:30 a.m. - 9:00 a.m.	Welcome and Opening Remarks
9:00 a.m. - 10:00 a.m.	Keynote Speaker: Dr. C. Everett Koop
Former Surgeon General of the United States and currently Senior Scholar and Elizabeth DeCamp McInerny Professor of Surgery at the C. Everett Koop Institute, Dartmouth College, Dr. Koop will describe his vision of global tobacco research and control for the next decade.
10:00 a.m. - 10:30 a.m.	Refreshment Break
10:30 a.m. - 11:30 a.m.	Theme Lecture: "The Neurobiology of Nicotine Dependence: An Allostatic View"
George Koob, Ph.D., Professor and Director of the Division of Psychopharmacology in the Department of Neuropharmacology at The Scripps Research Institute and Adjunct Professor of Psychology and Psychiatry at the University of California, San Diego.
11:30 a.m. - 2:30 p.m.	Poster Session 1
11:30 a.m. - 3:30 p.m.	Exhibit Hall open
1:30 p.m. - 3:00 p.m.	Symposium 1 CHANGES IN GENE EXPRESSION IN RESPONSE TO NICOTINE: MOLECULAR AND GENETIC APPROACHES David J. Vandenbergh*, Pennsylvania State University, Marina R. Picciotto, Yale University School of Medicine, Ming Li, University of Texas Health Sciences Center at San Antonio, Jerry Stitzel, University of Michigan
	Symposium 2 DENICOTINIZED OR NICOTINE-FREE CIGARETTES AS RESEARCH AND TREATMENT TOOLS Jed E. Rose, Ph.D. Wallace B. Pickworth, Ph.D. Kenneth A. Perkins, Ph.D. Laura Juliano, Ph.D. Neal L. Benowitz, M.D
	Symposium 3 INNOVATIVE APPROACHES TO YOUTH TOBACCO CONTROL Kenneth E. Warner, Ph.D., University of Michigan, Melanie Wakefield, Ph.D., The Cancer Council Victoria, Jack E. Henningfield, Ph.D., Johns Hopkins University, Robin Mermelstein, Ph.D., University of Illinois at Chicago, Matthew C. Farrelly, Ph.D., Research Triangle Institute
3:00 p.m. - 3:30 p.m.	Refreshment Break
3:30 p.m. - 4:00 p.m.	Members' Meeting
4:00 p.m. - 5:00 p.m.	Young Investigators Paper Session
	4:00 pm EFFECT OF PHYSICIAN CLINICAL INTERVENTIONS ON INDICATORS OF CESSATION A. Hyland, H. Xu, M. Mahoney, D. Levy, J. Bauer, G. Giovino, K.M. Cummings
	4:15 pm PSYCHOPATHOLOGY AND SOCIAL ENVIRONMENTS IN THE PROGRESSION FROM INITIATION OF TOBACCO USE TO NICOTINE DEPENDENCE Scott P. Novak, Ph.D., Brown University Stephen L. Buka, Sc.D., Harvard School of Public Health
	4:30 pm MISSED OPPORTUNITIES FOR SMOKING CESSATION INTERVENTION FOR FATHERS OF BABIES BEING TREATED IN A SPECIAL CARE NURSERY Olga Nin, Kelvin Chan, Bruce Becker M.D., Beth Bock Ph.D. & Rosa Carmona-Barro, M.S. Brown Medical School.
	4:45 pm HOW VALID ARE SELF-REPORT AND BIOCHEMCIAL MEASURES OF YOUTH SMOKING, REDUCTION AND CESSATION? Paul W. McDonald, Ph.D.,* Karen Pieters, MSc., K. Stephen Brown, Ph.D, Terry Stewart, M.A. and Linda Jessup
5:00 p.m. - 6:30 p.m.	Awards Presentation
6:30 p.m. - 7:30 p.m.	Opening Reception
Friday, February 21, 2003
8:00 a.m. - 10:00 a.m.	Paper Session 1 Mechanisms of Adolescent Smoking: Human and Animal Models
	8:00 am PRENATAL TOBACCO EXPOSURE: A CONTINUED RISK FACTOR FOR ADOLESCENT SMOKING Marie D. Cornelius, Ph.D., Sharon L. Leech, MPH, Nancy L. Day, Ph.D.
	8:15 am MORNING PLASMA LUTEINIZING HORMONE CONCENTRATIONS IN PRE-ADOLESCENT MALES PREDICTS REGULAR SMOKING IN MID-ADOLESCENCE Howard B. Moss, M.D., Lenae White, M.D., University of Pennsylvania School of Medicine; Jeffrey K. Yao, Ph.D., University of Pittsburgh School of Medicine
	8:30 am SINGLE TRIAL CONDITIONED REINFORCEMENT AND LOCOMOTOR SENSITIZATION IN ADOLESCENT RATS. Frances M. Leslie Ph.D., Alex Lee B.S., Heather Oliff Ph.D. and James Belluzzi Ph.D., University of California Irvine TTURC, Irvine CA 92697.
	8:45 am ADOLESCENT NICOTINE EXPOSURE RESULTS IN SENSITIZATION TO NICOTINE IN ADULTHOOD Martha M. Faraday, Ph.D., Brenda M. Elliott, M.S., Jennifer M. Phillips, B.S., and Neil E. Grunberg, Ph.D., Uniformed Services University of the Health Sciences
	9:00 am REPEATED EARLY METHYLPHENIDATE EXPOSURE ALTERS NICOTINE CONSUMPTION BY PERIADOLESCENT C57BL/6J MALE MICE Michele McClellan Stine, M.Ed.* and Laura Cousino Klein, Ph.D., Pennsylvania State University
	9:15 am INVOLVEMENT OF OPIATE RECEPTORS IN NICOTINE PHYSICAL DEPENDENCE M. Imad Damaj, Ph.D., Billy R. Martin, Ph.D., Virginia Commonwealth University, Dept. Pharmacology, Richmond, VA, 23298.
	9:30 am WHY DO ADOLESCENTS GET ADDICTED TO NICOTINE? EFFECTS ON CHOLINERGIC SYSTEMS IN A RAT MODEL Yael Abreu-VillaÁa, Ph.D.*, Frederic J. Seidler, Ph.D., Dan Qiao, Ph.D., Charlotte A. Tate, B.S.
	9:45 am NICOTINE INDUCED CFOS MRNA ACTIVATION IN ADOLESCENT BRAIN Sandra E. Loughlin*, Michelle Cheng, Heather Oliff and Frances M. Leslie
	Paper Session 2 Nicotine Dependence: Codependence and Comorbidity
	8:00 am CORRELATION BETWEEN SEVERITY OF NICOTINE DEPENDENCE AND BENZODIAZEPINE RECEPTOR BINDING IN ALCOHOLICS Julie K. Staley Ph.D., Ismene Petrakis, M.D., Gilles Tamagnan, Ph.D., Suchitra Krishnan-Sarin Ph.D., Edward Perry, M.D., John P. Seibyl M.D., Stephanie O'Malley Ph.D., and John H. Krystal M.D., Yale University School of Medicine & VACHS
	8:15 am CONCURRENT VS. DELAYED TREATMENT FOR NICOTINE DEPENDENCE FOR PATIENTS IN INTENSIVE TREATMENT FOR ALCOHOL DEPENDENCE Anne Joseph, M.D., MPH*, Mark Willenbring, M.D., Sean Nugent, B.A., Dave Nelson Ph.D., University of Minnesota, Center for Chronic Disease Outcomes Research, Minneapolis, MN
	8:30 am EFFICACY OF NICOTINE REPLACEMENT IN SMOKERS WITH AND WITHOUT PAST ALCOHOL PROBLEMS Hughes, J.R., Novy, P.M., Hatsukami, D.K., Jensen, J., Callas, P.M.
	8:45 am NICOTINE DEPENDENCE SERVICES IN METHADONE AND OTHER OPIOID TREATMENT FACILITIES Kimber Paschall Richter, Won S. Choi, Robert M. McCool, Kari J. Harris, Jasjit S. Ahluwalia
	9:00 am NICOTINE AND DRUG INTERACTION EXPECTANCIES AMONG METHADONE MAINTAINED CIGARETTE SMOKERS Michael D. Stein, M.D.*, Debra S. Herman, Ph.D, Shaughna Bishop, Marjorie Weinstock, Ph.D., Jennifer Anthony, Ph.D., Bradley J. Anderson, Ph.D.
	9:15 am DIFFERENTIAL RESPONSE TO NICOTINE REPLACEMENT THERAPIES IN OBESE AND NON-OBESE SMOKERS Caryn Lerman, Janet Audrain,Freda Patterson, Vyga Kaufmann, Margaret Rukstalis, Paul Wileyto, Susan Kucharski, Chris Jepson
	9:30 am PROJECT READY: A MOTIVATIONAL INTERVENTION TO REDUCE SMOKING AND NONADHERENCE AMONG SMOKERS WITH HIV Karen S. Ingersoll, Ph.D.*, Stephanie Fox, Psy.D., and Carolyn Heckman-Stone, Ph.D., Virginia Commonwealth University, Division of Addiction Psychiatry, Box 980109, Richmond, VA 23298-0109
	9:45 am CHARACTERISTICS OF PSYCHIATRIC PATIENTS WITH NICOTINE PROBLEMS Ivan D. Montoya(1), Diane M. Herbeck (2), Dace S. Svikis (3) (1) National Institute on Drug Abuse, Division of Treatment Research and Development; (2)American Psychiatric Institute for Psychiatric Research and Education, Practice Research Network; (3) Virginia Commonwealth University
	Paper Session 3 Tobacco Use and Risk Reduction
	8:00 am THE FRENCH MINISTERIAL REPORT ON TOBACCO RISK REDUCTION Gerard Dubois, Chairman of the Ministerial Working Group
	8:15 am WHAT DO MARLBORO LIGHT SMOKERS KNOW ABOUT LOW-TAR CIGARETTES? K.M. Cummings, M.A. Bansal, A. Hyland, B. Yost, G. Giovino
	8:30 am DESIGNING THE PERFECT DRUG DELIVERY DEVICE: MANIPULATION AND CONTROL OF CIGARETTE SMOKE YIELD, INTAKE, AND SMOKER BEHAVIOR Ferris Wayne, Geoffrey; Connolly, Greg N
	8:45 am ARE SMOKERS ADEQUATELY INFORMED ABOUT CIGARETTE PRODUCT CHARACTERISTICS AND THE HEALTH RISKS OF SMOKING? K.M. Cummings, M.A. Bansal, J. Bauer, J. Hastrup, G. Giovino, B. Yost, A. Hyland
	9:00 am DO REDUCED EXPOSURE PRODUCTS ACTUALLY REDUCE EXPOSURE? NITROSAMINE LEVELS IN ADVANCE USERS Alison Breland*, M.S., August R. Buchhalter, Ph.D. and Thomas Eissenberg, Ph.D.
	9:15 pm SMOKING BEHAVIOR AND CARBON MONOXIDE AND COTININE LEVELS WITH A “REDUCED RISK” CIGARETTE (OMNI) VS TRADITIONAL CIGARETTES Hughes, J.R., Keely, J., Iula, E., Hirsch, J.
	9:30 am ROLE OF SNUS (ORAL MOIST SNUFF) IN SMOKING CESSATION AND SMOKING REDUCTION AMONG SWEDISH MEN Hans Gilljam M.D, Ph.D., M.Rosaria Galanti M.D, Ph.D., Karolinska Institute, Centre for Tobacco Prevention, Stockholm Centre for Public Health
	9:45 am WHAT IS THE EFFECT OF INCREASES IN CIGARETTE EXCISE TAXES ON THE REAL COST OF CIGARETTES TO THE CONSUMER? Pamela I. Clark, Ph.D.,* Jaana Myllyluoma, Ph.D., Charles Wolters, M.S., (Battelle Centers for Public Health Research and Evaluation); Kurt Ribisl (University of North Carolina, Chapel Hill), Ellen Feighery, M.S., Nina Schleicher, Ph.D. (Public Health Institute)
10:00 a.m. - 10:30 a.m.	Refreshment Break
10:30 a.m. - 11:30 a.m.	Theme Lecture: "Science & Policy: Mighty Weapons in a 'Black Flag' War"
Nancy J. Kaufman, Former President, The Strategic Vision Group, Vice President of the Robert Wood Johnson Foundation
11:30 a.m. - 1:30 p.m.	Poster Session 2
11:30 a.m. - 7:30 p.m.	Exhibit Hall open
1:30 p.m. - 3:00 p.m.	Symposium 4 SEX-SPECIFIC EFFECTS IN NICOTINE WITHDRAWAL: THE ROLE OF PSYCHIATRIC, COGNITIVE, AND HORMONAL FACTORS Co-Chairs: Carolyn M. Mazure Ph.D. & Stephanie S. O'Malley, Ph.D., Yale University School of Medicine; Discussant: Kenneth A. Perkins, Ph.D., University of Pittsburgh; Presenters: Sherry A. McKee, Ph.D., Suchitra Krishnan-Sarin, Ph.D., Yale University
	Symposium 5 TOBACCO TREATMENT EVALUATION: ACHIEVING TRANSDISCIPLINARY INTEGRATION Timothy B. Baker, Ph.D., University of Wisconsin; Dorothy Hatsukami, Ph.D., University of Minnesota; Caryn Lerman, Ph.D., University of Pennsylvania; Stephanie O'Malley, Ph.D., Yale University; Alexandra Shields, Ph.D., Georgetown University & Michael Fiore, M.D., M.P.H., University of Wisconsin Medical School
	Symposium 6 TOWARDS A HEALTH SERVICES RESEARCH AGENDA THAT SUPPORTS THE ADOPTION OF TOBACCO TREATMENT Paul A. Fishman, Ph.D., Group Health Cooperative; Susan J. Curry, Ph.D., University of Illinois-Chicago; Susan H. Swartz, M.D., Maine Medical Center
3:00 p.m. - 3:30 p.m.	Refreshment Break
3:30 p.m. - 5:30 p.m.	Paper Session 4 Genes and Ethnicity: Contributions to Nicotine and Sensitivity and Tobacco Use
	3:30 pm HEIGHTENED REACTIVITY TO SMOKING CUES AS A FUNCTION OF DOPAMINE TRANSPORTER (SLC6A3) GENOTYPE Joel Erblich, Ph.D.*, Yael Boyarsky, B.A., Mount Sinai School of Medicine, Caryn Lerman, Ph.D., University of Pennsylvania School of Medicine, George Diaz, M.D., Ph.D., Dana Bovbjerg, Ph.D., Mount Sinai School of Medicine.
	3:45 pm TRANSCRIPTOSOME COMPARISON IN HIPPOCAMPUS OF SMOKERS AND NON-SMOKERS: DIFFERENTIAL REGULATION BY SMOKING IN SCHIZOPHRENIA. S. Leonard , S. Wang, M. Frank, R. Berger
	4:00 pm PHARMACOKINETIC MECHANISM OF TOXICITY FROM TRANSDERMAL NICOTINE IN NONSMOKERS Neal L. Benowitz, M.D.,* Delia Dempsey, M.D., Faith Allen, M.D., Peyton Jacob III, Ph.D.
	4:15 pm GENETIC AND ENVIRONMENTAL INFLUENCES ON MULTIPLE TOBACCO-RELATED PHENOTYPES IN FAMILIES Li S-C Cheng(1), Gary E. Swan(2), Dorit Carmelli(2), Hyman Hops(3), Judy Andrews(3), Elizabeth Tildesley(3), Kymberli Hemberger(2), and Karen Hudmon(4) (1)City of Hope National Medical Center, (2)SRI International, (3)Oregon Research Institute, (4) UCSF
	4:30 pm SENSITIVITY TO NICOTINE AND FAMILIAL SMOKING David J. Drobes, Ph.D.*, University of South Florida; Michael E. Saladin, Ph.D., and Robert J. Malcolm, M.D., Medical University of South Carolina; Patricia L. Fiero, Ph.D., National Cancer Institute
	4:45 pm DIFFERENCES IN PLATELET SEROTONIN TRANSPORTER SITES BETWEEN AFRICAN-AMERICAN TOBACCO SMOKERS AND NONSMOKERS A .A. Patkar, M.D.*, R. Gopalakrishnan, M.D., V. Batra, M.D., A. M. Desai, B.S., S. Weinstein, PhD, F. Leone, M.D.
	5:00 pm SMOKING TOPOGRAPHY AND EXPOSURE ACROSS LEVELS OF CIGARETTE AVAILABILITY IN BLACK AND WHITE WOMEN Karen Ahijevych, Ph.D.*, Harrison Weed,M.D., Jo Clarke, C.N.P., M.S., Ohio State University
	5:15 pm THE FAMILIAL TRANSMISSION OF HABITUAL SMOKING IN ALCOHOL DEPENDENT FAMILIES: DIFFERENCES BETWEEN CAUCASIAN AND AFRICAN-AMERICAN L. J. Bierut, L. Mettenburg, H. Begleiter, R. Crowe, V. Hesselbrock, J. I. Nurnberger Jr., B. Porjesz, M. Schuckit, R. Taylor, and T. Reich and the Collaborative Study of the Genetics of Alcoholism (COGA)
	Paper Session 5 Constructs, Cues and Expectancies
	3:30 pm FACTOR STRUCTURE OF A SURVEY-BASED SCALE OF ADOLESCENT SMOKING-RELATED COGNITIONS ACROSS ETHNIC GROUPS Laura MacPherson, B.A.*, San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology; Mark G. Myers, Ph.D. V.A. San Diego Healthcare System and University of California, San Diego
	3:45 pm THE MEASUREMENT PROPERTIES OF A NICOTINE DEPENDENCE SCALE FOR ADOLESCENTS: FURTHER EVIDENCE James M. Nonnemaker, Ph.D.*, Christian T. Nimsch, M.A.,RTI and M. Lyndon Haviland, Dr.P.H. American Legacy Foundation
	4:00 pm A NEW SELF-ADMINISTERED QUESTIONNAIRE TO MEASURE CIGARETTE WITHDRAWAL SYMPTOMS: THE CIGARETTE WITHDRAWAL SCALE (CWS-20) Jean-Francois Etter
	4:15 pm VALIDATION AND REPLICATION OF THE NICOTINE EFFECTS QUESTIONNAIRE Raymond Niaura, Ph.D.1*, Brian Hitsman, Ph.D.1, David B. Abrams, Ph.D.1, Damaris J. Rohsenow, Ph.D.2, & Peter M. Monti, Ph.D.2 1Brown Medical School and The Miriam Hospital 2Providence VA Medical Center and Brown University
	4:30 pm EFFECTS OF REPEATED DAYS OF SMOKING CUE EXPOSURE ON SUBJECTIVE AND PHYSIOLOGIC REACTIVITY Robert Miranda, Damaris Rohsenow, Peter Monti, Jennifer Tidey, & Robert Swift Center for Alcohol and Addiction Studies, Brown University Providence VA Medical Center
	4:45 pm COMPARING PERSONALIZED SMOKING CUES AND STANDARDIZED SMOKING CUES IN REGULAR SMOKERS William G. Shadel, Ph.D., University of Pittsburgh; Raymond Niaura, Ph.D. and David B. Abrams, Ph.D., Brown Medical School
	5:00 pm TAILORED INTERVENTIONS FOR SMOKING CESSATION: THE EFFECTS OF PLACEBO-TAILORING AND EXPECTANCIES Monica S. Webb, B.S., Vani Nath, M.A., and Thomas H. Brandon, Ph.D.
	5:15 pm COMPARATIVE EFFICACY OF RAPID-RELEASE NICOTINE GUM VS. NICORETTE® IN RELIEVING SMOKING CUE-PROVOKED CRAVING Raymond Niaura Ph.D.*1, Michael Sayette, Ph.D.2, Saul Shiffman, Ph.D. 2, E.D. Glover, Ph.D.3, Mitch Nides, Ph.D. 4, Morris Shelanski, M.D. 5, William Shadel,Ph.D. 1, 2, Bruce Robbins, PharmD6, Jim Sorrentino, Ph.D.6; 1Brown Medical School, 2U. Pittsburgh, 3West Virginia U., 4LA Clinical Trials, 5Product Investigations Inc., 6Bayer Consumer Care
	Paper Session 6 Environmental Tobacco Smoke: Research and Policy
	3:30 pm ASSOCIATION BETWEEN EXPOSURE TO WORKPLACE SECOND-HAND SMOKE AND REPORTED RESPIRATORY AND SENSORY SYMPTOMS: CROSS-SECTIONAL STUDY Melanie Wakefield*, Lisa Trotter, Melissa Cameron, Graeme Inglis and David Hill, The Cancer Council Victoria, Australia; Alistair Woodward, Department of Public Health, University of Otago, New Zealand.
	3:45 pm DEFIANCE OF SMOKEFREE BAR POLICY: STRUCTURED OBSERVATIONS IN SAN FRANCISO BARS Roland S. Moore, Ph.D.*, and Juliet P. Lee, Ph.D., Prevention Research Center, Pacific Institute for Research & Evaluation
	4:00 pm INFLUENCING PUBLIC POLICY: ENVIRONMENTAL TOBACCO SMOKE EXPOSURE IN TULSA Frank L. Collins, Jr. Ph.D., Ernestine Green-Turner, B.S., Oklahoma State University; Clay Gemmill, M.S., Tulsa City-County Health Department; C. Katherine Hammond, University of California-Berkeley
	4:15 pm KNOWLEDGE, ATTITUDES, AND PERCEPTIONS ABOUT ENVIRONMENTAL TOBACCO SMOKE AMONG LOUISIANANS M. Magnus*, C. Ehlen, G. Babatsikos, E. Gleckler, K. Sawyer, L. Moses, P. Kissinger
	4:30 pm EXPOSURE TO SECOND HAND SMOKE IN CANADIAN HOME ENVIRONMENTS: A NATIONAL STUDY Roberta Ferrence Ph.D., * Rachel Dioso M.A., Mary Jane Ashley M.D., Joanna Cohen Ph.D., Marilyn Pope BSc, Joan M. Brewster Ph.D., Blake Poland Ph.D., Ontario Tobacco Research Unit, University of Toronto; David Northrup M.A., York University
	4:45 pm RELATIONSHIP OF CLEAN INDOOR AIR POLICIES AT WORK, HOME, AND IN THE FAMILY CAR WITH CESSATION BEHAVIORS J.E. Bauer*, A. Hyland, Q. Li, G. Giovino, and K.M. Cummings
	5:00 pm REDUCING ENVIRONMENTAL TOBACCO SMOKE EXPOSURE IN PRIVATE PLACES: A QUALITATIVE STUDY OF TOBACCO CONTROL ADVOCATES Kim Bercovitz, Sandra Colavecchia, Joanna Cohen, Roberta Ferrance, Blake Poland, Peter Selby and Donna Stewart.
	5:15 pm USING DRUG TESTING TO IMPROVE ESTIMATES OF POPULATION TOBACCO SMOKE EXPOSURE Michael Fendrich, Amy Hubbell, Mary Ellen Mackesy-Amiti
5:30 p.m. - 7:30 p.m.	Poster Session 3
7:30 p.m. – 8:30 p.m.	Association for the Treatment of Tobacco Use and Dependence Meeting Informational meeting for interested therapists and treatment providers
7:30 p.m. – 9:30 p.m.	Grant-Writing for the New Investigator: Everything You’ve Always Wanted to Know But Were Afraid to Ask
7:30 p.m. – 9:30 p.m.	The Evidence for Youth Smoking Cessation Meeting
Saturday, February 22, 2003
8:00 a.m. - 10:00 a.m.	Paper Session 7 Biopsychosocial Contributors to Tobacco Use
	8:00 am MOST SMOKELESS TOBACCO USE IS NOT A CAUSAL GATEWAY TO CIGARETTES: USING ORDER OF PRODUCT USE TO EVALUATE CAUSATION IN A NATIONAL US SAMPLE Richard J. O’Connor*, Lynn T. Kozlowski , Beth Ann Quinio, and Brian P. Flaherty Departments of Biobehavioral Health (LTK, RJO, BAQ) and Human Development and Family Studies (BPF), The Pennsylvania State University
	8:15 am WEIGHT CONCERN AND ITS RELATIONSHIP TO THE INITIATION AND ESCALATION OF SMOKING AMONG 6TH GRADE STUDENTS: A PRELIMINARY REPORT Susan Albrecht*, Ph.D., R.N., Yookyung Kim, Ph.D., Beth Kuzminsky, M.S.N., R.N., Patricia L. Lasher, M.S.N., R.N., & Tracey A. Florio, M.S.N., R.N., University of Pittsburgh
	8:30 am THE INFLUENCE OF DEPRESSIVE SYMPTOMS ON SMOKING BEHAVIOR & INTENTION TO SMOKE IN ACCULTURATING YOUTH Elahe Nezami, Ph.D., Anamara Ritt-Olson*, MA, Sylvia Tan, MS, Selena Nguyen, Jennifer Unger, Ph.D., Jennifer Hanna, Ana Romero, & C. Anderson Johnson, Ph.D. Institute for Health Promotion & Disease Prevention Research, Keck School of Medicine, University of Southern California
	8:45 am THE IMPACT OF DEPRESSION AND PHYSICAL ACTIVITY ON SMOKING PROGRESSION Daniel Rodriguez, Ph.D. & Janet Audrain-McGovern, Ph.D. Department of Psychiatry, University of Pennsylvania
	9:00 am AN ATTEMPT TO UNDERSTAND INDIVIDUAL DIFFERENCES AMONG SMOKERS USING THE BIG FIVE PERSONALITY FACTORS William G. Shadel, Ph.D., University of Pittsburgh; Daniel Cervone, Ph.D., University of Illinois at Chicago; Raymond Niaura, Ph.D. and David B. Abrams, Ph.D., Brown Medical School
	9:15 am IDENTIFYING CLUSTER SUBTYPES FOR THE PREVENTION OF SMOKING ACQUISITION Wayne F. Velicer. Ph.D*., Colleen A. Redding, Ph.D., Richard Broomfield, M. S., James O. Prochas
	9:30 am THE EFFECTS OF TRAUMA RECALL ON SMOKING TOPOGRAPHY IN PTSD AND NON-PTSD TRAUMA SURVIVORS F. Joseph McClernon, Ph.D., Jean C. Beckham, Ph.D.*, Susannah L. Mozley, Ph.D., Michelle E. Feldman, B.A., and Jed E. Rose, Ph.D., Duke University and VA Medical Centers, Durham, NC.
	9:45 am ADULT TOBACCO SURVEILLANCE AND THE IMPACT OF SEPTEMBER 11TH ON SMOKING BEHAVIOR IN NEW JERSEY Cristine Delnevo, Ph.D., MPH., Mary Hrywna, MPH., UMDNJ-School of Public Health
	Paper Session 8 Gender and Smoking: Initiation, Effects, and Treatment
	8:00 am GENDER DIFFERENCES IN THE PREDICTION OF INITIATION OF CIGARETTE SMOKING Judy A. Andrews*, Ph. D. Missy Peterson, M. A., Elizabeth A. Tildesley, Ph. D., Hyman Hops, Ph. D. & Herbert Severson, Ph. D.
	8:15 am GIRLS WHO START TO SMOKE EARLIER ARE DIFFERENT AND HAVE MORE TROUBLES Carlos Cortijo, F.Javier Ayesta
	8:30 am PREDICTORS OF RAPID PROGRESSION TO REGULAR CIGARETTE SMOKING AMONG ADOLESCENTS: INTERACTIONS WITH GENDER AND ETHNICITY. Jonathan L. Blitstein, M.S., Leslie A. Robinson, Ph.D., and David M. Murray, Ph. D.
	8:45 am GENDER DIFFERENCES IN POSITIVE AND NEGATIVE AFFECT IN RESPONSE TO SMOKING FOLLOWING OVERNIGHT ABSTINENCE Raymond Niaura, Ph.D.*, Brian Hitsman, Ph.D., David B. Abrams, Ph.D., Brown Medical School and The Miriam Hospital
	9:00 am PITUITARY-ADRENOCORTICAL RESPONSES TO STRESS AND NEGATIVE AFFECT AS PREDICTORS OF SMOKING RELAPSE IN MEN AND WOMEN Mustafa al'Absi, Ph.D., Deanna Ellestad, R.N., and Gary L. Davis, Ph.D., University of Minnesota School of Medicine
	9:15 am EFFICACY OF NALTREXONE IN SMOKING CESSATION: EFFECTS OF GENDER ON CLINICAL RESPONSE Andrea King, Ph.D.1, Elizabeth Chilton, B.A. 1, Dorothy Hatsukami, Ph.D., 2 & Raymond Niaura, Ph.D.3 1 University of Chicago 2University of Minnesota 3Brown University
	9:30 am DO MEN AND WOMEN DIFFER IN RESPONSE TO NICOTINE REPLACEMENT THERAPY: A META-ANALYSIS. MR Munafu, M Bradburn, L Bowes, S David, MFG Murphy.
	9:45 am HETEROGENEITY IN 12-MONTH OUTCOME FOLLOWING TREATMENT FOR SMOKING CESSATION AMONG FEMALE SMOKERS Gary E. Swan, Ph.D.(1)*, Lisa M. Jack, M.A.(1), Susan J. Curry, Ph.D.,(2) Harold S. Javitz, Ph.D..((1), Tim McAfee, M.D., M.P.H.(2). (1)SRI International; ((2) Group Health Cooperative.
	Paper Session 9 Tobacco Use in Adolescents and Young Adults
	8:00 am APPLYING A BEHAVIORAL ECONOMIC FRAMEWORK TO UNDERSTANDING ADOLESCENT SMOKING Janet Audrain-McGovern, Ph.D., University of Pennsylvania; Kenneth P. Tercyak, Ph.D.,Georgetown University; Leonard H. Epstein, Ph.D., State University of New York at Buffalo, & E. Paul Wileyto,Ph.D.,University of Pennsylvania.
	8:15 am STABILITY AND CHANGE IN CIGARETTE SMOKING CLASSES OF U.S. ADOLESCENTS. Brian P. Flaherty, M.S. and Linda M. Collins, Ph.D., The Pennsylvania State University
	8:30 am DO CHANGES IN MOOD FOLLOWING SMOKING PREDICT LONGITUDINAL CHANGES IN ADOLESCENT SMOKING PATTERNS? Robin Mermelstein, Ph.D., Donald Hedeker, Ph.D, Brian Flay, D.Phil, University of Illinois at Chicago, Saul Shiffman, Ph.D., University of Pittsburgh
	8:45 am ARAB AMERICAN ADOLESCENT TOBACCO USE Virginia Hill Rice, Ph.D., R.N.; Linda Weglicki, Ph.D., R.N.; Anahid Kulwicki, DNSc, R.N.; Thomas Templin, Ph.D.; Hikmet Jamil, M.D., Ph.D.; Omar Baker, MSN; Hasan Al-Omran, MSN; Wayne State University. Adnan Hammad, Ph.D., Arab Community Center for Economic and Social Service
	9:00 am WHY THE RECENT DROP IN CALIFORNIA ADOLESCENT SMOKING PREVALENCE? Elizabeth A. Gilpin, M.S., Lora Lee, M.S., John P. Pierce, Ph.D., University of California, San Diego
	9:15 am A DECLINE IN SMOKING PREVALENCE AMONG U.S. COLLEGE STUDENTS BETWEEN 1999 AND 2001 Nancy A. Rigotti, M.D., Tobacco Research and Treatment Center, Massachusetts General Hospital, Harvard Medical School; Henry Wechsler, Ph.D., Jae Lee, Ph.D., Harvard School of Public Health
	9:30 am SOCIAL SMOKING BY U.S. COLLEGE STUDENTS Susan Moran, M.D., MSCE*, Nancy A. Rigotti, M.D., Massachusetts General Hospital, Tobacco Research and Treatment Center; Henry Wechsler, Ph.D., Harvard School of Public Health.
	9:45 am THE EFFECTS OF TOBACCO COUNTERMARKETING CAMPAIGNS ON YOUTH PERCEPTIONS OF PEER SMOKING Kevin C. Davis, M.A., James M. Nonnemaker, Ph.D., and Matthew C. Farrelly, Ph.D., RTI; M. Lyndon Haviland, Dr.PH., American Legacy Foundation
10:00 a.m. - 10:30 a.m.	Refreshment Break
10:30 a.m. - 11:30 a.m.	Theme Lecture: Treating Tobacco Dependence; Evaluating Evidence, Evaluating "Assumptions"
Michael Fiore, M.D., M.P.H., Professor of Medicine, Director, Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison, Wisconsin
10:30 a.m. - 1:30 p.m.	Exhibit Hall open
11:30 a.m. - 1:30 p.m.	Poster Session 4
1:30 p.m. - 3:00 p.m.	Symposium 7 TOBACCO EXPOSURE REDUCTION Dorothy K. Hatsukami, Mark LeSage, Stephen Hecht, Sharon Murphy, Charlotte Lemmonds, Anne Joseph, Neal Benowitz
	Symposium 8 WOMEN, GENDER, AND SMOKING CESSATION Joy M. Schmitz, Ph.D., University of Texas Medical School; Robin Mermelstein, Ph.D., University of Illinois at Chicago; Lirio Covey, Ph.D., Columbia University; Timothy B. Baker, Ph.D., University of Wisconsin; David W. Wetter, Ph.D., University of Texas
	Symposium 9 TRANSLATING EVIDENCE-BASED TOBACCO INTERVENTIONS INTO PRACTICE AND POLICY C. Tracy Orleans, Ph.D., The Robert Wood Johnson Foundation (RWJF) Princeton, NJ; Susan Curry, Ph.D., University of Illinois-Chicago, Chicago, IL; Cathy L. Melvin, Ph.D., M.PH,. University of North Carolina-Chapel Hill, Chapel Hill, NC
3:00 p.m. - 3:30 p.m.	Refreshment Break
3:30 p.m. - 5:30 p.m.	Presidents' Symposium TOBACCO USE BY YOUNG ADULTS: CHALLENGES AND OPPORTUNITIES FOR INTERVENTION Nancy A. Rigotti, M.D., Paula Lantz, Ph.D., Pamela Ling, M.D., M.PH., Harry Lando, Ph.D., Virginia Quinn, Ph.D.; discussant: Tracy Orleans, Ph.D. Closing Remarks
6:00 p.m. - 8:00 p.m.	Post Meeting Workshop: Tobacco Industry Funding and Scientific Research: Ethical, Legal and Policy Issues Keynote address and reception in the Waterbury Room.
Sponsored by the American Legacy Foundation, the California Tobacco-Relate Disease Research Program, the National Cancer Institute, and the Society for Research on Nicotine and Tobacco.
Registration for this workshop is complimentary, however, space is limited and pre-registration is required. For more information, please email us at tobacco@pyramidcommunications.com.
February 23, 2003
7:00 a.m. - 5:00 p.m.	Post Meeting Workshop: Tobacco Industry Funding and Scientific Research: Ethical, Legal and Policy Issues In the Waterbury Room
Ethical and legal issues, funding arrangements and rules of engagement.

All potential attendees of the SRNT Annual Meeting should be aware that an individual's current or past employment history is not a criterion on which SRNT bases registration decisions. Thus, meeting attendees may include representatives of the tobacco industry.